Lumida
/JYNT
⌘K
Joint Corp

Joint Corp

JYNT
$8.91USD↓-1.22%-0.11 today

MARKET CAP

127.0M

P/E (TTM)

82.9x

FWD P/E

31.4x

DAY RANGE

$9 – $9

52W RANGE

$8
$12

AI Summary

Stalk
Buy NowMedium

JYNT is in Stage 2 advancing, having built a clear higher‐highs/higher‐lows sequence off its May lows and trading above rising 9/21/50 EMAs on expanding volume. Active Lockout Rally and HH/HL patterns reinforce bullish continuation, while short‐term pullbacks into the EMAs are supported. Despite overbought signals and a declining 200 DMA overhead, timing conditions favor immediate participation to ride further upside momentum.

  • ↑Joint 2.0 franchising rollout on track for year-end completion.
  • ↑Franchise licenses sold rose to 13 in Q1 2026 versus 7 a year ago.
  • ↓Comparable store sales declined 4.2%, highlighting patient acquisition challenges.
Full analysis →
Insider Trades1 trades
Date↓SideTicker↕Insider↕Role↕Shares↕Price↕Mkt Cap↕52W High↕52W Low↕Value↕% Chg↕Rule↕AI View↕
Jun 10, 2026SellJYNTScott Justin BowmanChief Financial Officer1,392$8.43$127.0M-24.36%+18.80%$11.7K-2.88%—Buy Now